site map  

Osteonectin (SPARC)

  PRODUCTS ORDERING SERVICES ABOUT US FAQ/TECH NOTES CONTACT

Human Proteins   Bovine Proteins   Mouse Proteins   Other Species  Inhibitors

   Substrates   Antibodies   Sample Collection Tubes  Assay Kits  Deficient Plasmas  Pricing

 

 

 


Haematologic Technologies, Inc.

57 River Road

Essex Junction, VT USA

Tel: 802.878.1777

Fax: 802.878.1776

Email: hti@haemtech.com

HOME PAGE

DOMAIN STRUCTURE OF HUMAN OSTEONECTIN The domain structure of human osteonectin is illustrated, where: CHO = potential glycosylation sites, OP = potential serine phophorylation sites, EF-Hand = regions homologous to calcium binding domains in calmodulin, and acidic = NH2-terminal acidic domain.

Osteonectin is an acidic, noncollagenous glycoprotein (Mr=29,000) originally isolated from fetal and adult bovine bone matrix (1-5). In vitro bovine bone osteonectin binds type I collagen, calcium (Kd=3x10-7 M) and hydroxyapatite (Kd=8x10-8 M) and has been shown to be a potent inhibitor of hydroxyapatite seeded crystal growth (6). In this context it has been suggested that osteonectin may play an important role in the regulation of bone metabolism by binding hydroxyapatite to collagen.  Recently, proteins homologous to osteonectin have been identified in a number of cell types, most of which are associated with extracellular matrix production (7). The amino acid sequence (from cDNA sequences) of one of these proteins, human placental SPARC is identical to human bone osteonectin. 

Osteonectin has also been identified as an alpha granule component of human platelets and is secreted during activation. A small portion of the secreted osteonectin is expressed on the platelet cell surface in an activation dependent manner (8). Purified platelet osteonectin is a single chain molecule which exhibits a slightly larger apparent molecular weight than that of osteonectin derived from bone (8). The NH2-terminal sequences of platelet and bone-derived osteonectin are identical, but the two proteins differ with regard to the extent ot glycosylation (8-10). 

Human platelet osteonectin is isolated from thrombin activated platelets as described by Kelm, et al. (8). Bovine bone osteonectin is isolated from demineralized bone by the method of Romberg et al. (2). Both proteins are supplied in 0.02 M Tris, 0.15 M NaCl, pH 7.4, and should be stored at -80oC. Purity is judged by SDS-PAGE analysis. 

Properties of Osteonectin

Localization: Bone, platelets, plasma (0.9 ug/ml)* (5), serum (2.6 ug/ml)** (5).
Mode of action: Unknown
Molecular weight: 32,700 (human bone, from cDNA) (1)
29,000 (bovine bone, by sedimentation equilibrium) (3)
Extinction coefficient:
E
1 %
1 c m, 280 nm
= 8.0
Isoelectric point: 5.5*** (3)
Structure: Single chain, NH2 terminal acidic domain, cysteine rich serpin homology domain, 2 EF hand domains.
Post-translational modifications: Phosphoserine (11)

* Determined for Human Plasma
** Determined for Human Serum
*** Determined for Bovine Bone

Catalog Number

Description

HON-0303

Human Osteonectin

BON-3010

Bovine Osteonectin

PRICING

INQUIRE ABOUT THIS PRODUCT

References 

1. Villarreal, X.C., et al., Biochemistry, 28, 6483 (1989). 
2. Termine, J.D., et al., J. Biol. Chem., 256, 10403 (1981). 
3. Romberg, R.W., et al., J. Biol. Chem., 260, 2728 (1985). 
4. Tracy, R.P., et al., Int. J. Biochem., 29, 653 (1988). 
5. Stenner, D.D., et al., Proc. Natl. Acad. Sci. USA, 83, 6892 (1986). 
6. Romberg, R.W., et al., Biochemistry, 25, 1176 (1986). 
7. Sage, E.H. and Bornstein, P.J., J. Biol. Chem., 266, 14831 (1991). 
8. Kelm, R.J. and Mann, K.G., J. Bone Min. Res., 4, 5245 (1989). 
9. Kelm, R.J. and Mann, K.G., Blood, 75, 1105 (1990). 
10. Kelm, R.J., et al., Blood, 80, 3112 (1992). 
11. Fisher, L.W., et al., J. Biol. Chem., 262, 9702 (1987). 

 Please inquire about products not listed.  We can also custom purify proteins from other species. 

© 2004 Haematologic Technologies, Inc. All Rights Reserved